1. Report of the WHO/ISFC task force on definition and classification of the cardiomyopathies;Brandenberg, R.O.; Chazov, E.; Cherian, G.;Circulation,1981
2. The Registry of the International Society for Heart Transplantation: seventh official report1990;Kriett, J.M.; Kaye, M.P.;J Heart Transplant,1990
3. Myosin-induced acute myocarditis is a T cell-mediated disease;Smith, S.C.; Allen, P.M.;J Immunol,1991
4. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-I and interleukin-2;Huber, S.A.; Polgar, J.; Schultheiss, P.; Schwimmbeck, P.;J Virol,1994
5. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies;Limas, C.J.; Goldenberg, I.F.; Limas, C.;Circulation,1995